HEADER LIPID BINDING PROTEIN 26-APR-07 2POG TITLE BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR B AGONISTS (SERBAS). PART TITLE 2 2: STRUCTURE ACTIVITY RELATIONSHIP STUDIES ON THE BENZOPYRAN TITLE 3 SCAFFOLD. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN (RESIDUES 304-551); COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR RECEPTOR, LIGAND-BINDING, LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.I.RICHARDSON,B.H.NORMAN,C.W.LUGAR,S.A.JONES,Y.WANG,J.D.DURBIN, AUTHOR 2 V.KRISHNAN,J.A.DODGE REVDAT 5 21-FEB-24 2POG 1 REMARK REVDAT 4 20-OCT-21 2POG 1 SEQADV REVDAT 3 18-OCT-17 2POG 1 REMARK REVDAT 2 24-FEB-09 2POG 1 VERSN REVDAT 1 11-SEP-07 2POG 0 JRNL AUTH T.I.RICHARDSON,B.H.NORMAN,C.W.LUGAR,S.A.JONES,Y.WANG, JRNL AUTH 2 J.D.DURBIN,V.KRISHNAN,J.A.DODGE JRNL TITL BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS JRNL TITL 2 (SERBAS). PART 2: STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON JRNL TITL 3 THE BENZOPYRAN SCAFFOLD. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 3570 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17485205 JRNL DOI 10.1016/J.BMCL.2007.04.051 REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2220994.750 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 45835 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4637 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2610 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2600 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4637 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 45835 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.84 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6795 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE : 0.3460 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 773 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3545 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.67000 REMARK 3 B22 (A**2) : -0.52000 REMARK 3 B33 (A**2) : -8.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.670 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.470 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.370 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.610 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 45.48 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2POG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042605. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL; NULL REMARK 200 TEMPERATURE (KELVIN) : NULL; NULL REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; NULL REMARK 200 RADIATION SOURCE : APS; NULL REMARK 200 BEAMLINE : 31-ID; NULL REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : NULL; NULL REMARK 200 MONOCHROMATOR : NULL; NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL; NULL REMARK 200 DETECTOR MANUFACTURER : NULL; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50399 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 25.203 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : 0.06800 REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.01200 REMARK 200 R SYM FOR SHELL (I) : 1.16300 REMARK 200 FOR SHELL : 0.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, PH 8.0, 0.2 M MGCL2, REMARK 280 20 % PEG 4000 AND 10% ETHYLENE GLYCOL., VAPOR DIFFUSION, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.54900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.54900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 30.29200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.90500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 30.29200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.90500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 86.54900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 30.29200 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.90500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 86.54900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 30.29200 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.90500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 ASP A 332 REMARK 465 PRO A 333 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PRO A 336 REMARK 465 PHE A 337 REMARK 465 SER A 338 REMARK 465 GLU A 339 REMARK 465 SER A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 VAL A 533 REMARK 465 ALA A 551 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 TYR B 331 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 337 REMARK 465 SER B 338 REMARK 465 GLU B 339 REMARK 465 ALA B 340 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 PRO B 535 REMARK 465 LEU B 536 REMARK 465 TYR B 537 REMARK 465 ASP B 538 REMARK 465 LEU B 539 REMARK 465 LEU B 540 REMARK 465 LEU B 541 REMARK 465 GLU B 542 REMARK 465 MET B 543 REMARK 465 LEU B 544 REMARK 465 ASP B 545 REMARK 465 ALA B 546 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 462 -95.03 -44.69 REMARK 500 THR B 460 32.21 -145.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I0G RELATED DB: PDB DBREF 2POG A 304 551 UNP P03372 ESR1_HUMAN 304 551 DBREF 2POG B 304 551 UNP P03372 ESR1_HUMAN 304 551 SEQADV 2POG SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2POG SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2POG SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 2POG SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2POG SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2POG SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQRES 1 A 248 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 A 248 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 A 248 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 A 248 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 A 248 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 A 248 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 A 248 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 A 248 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 A 248 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 A 248 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 A 248 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 A 248 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 A 248 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 A 248 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 A 248 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 A 248 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 A 248 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 A 248 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 A 248 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS SEQRES 20 A 248 ALA SEQRES 1 B 248 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 B 248 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 B 248 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 B 248 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 B 248 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 B 248 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 B 248 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 B 248 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 B 248 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 B 248 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 B 248 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 B 248 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 B 248 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 B 248 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 B 248 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 B 248 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 B 248 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 B 248 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 B 248 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS SEQRES 20 B 248 ALA HET WST A 201 21 HET WST B 301 21 HETNAM WST (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B- HETNAM 2 WST HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL FORMUL 3 WST 2(C18 H18 O3) FORMUL 5 HOH *118(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 341 ARG A 363 1 23 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ASN A 413 LYS A 416 5 4 HELIX 7 7 GLY A 420 ASN A 439 1 20 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLY A 457 PHE A 461 5 5 HELIX 10 10 THR A 465 ALA A 493 1 29 HELIX 11 11 THR A 496 MET A 528 1 33 HELIX 12 12 PRO A 535 ASP A 545 1 11 HELIX 13 13 LEU B 306 LEU B 310 5 5 HELIX 14 14 THR B 311 GLU B 323 1 13 HELIX 15 15 SER B 341 ARG B 363 1 23 HELIX 16 16 GLY B 366 LEU B 370 5 5 HELIX 17 17 THR B 371 SER B 395 1 25 HELIX 18 18 ARG B 412 SER B 417 1 6 HELIX 19 19 GLY B 420 ASN B 439 1 20 HELIX 20 20 GLN B 441 GLY B 457 1 17 HELIX 21 21 VAL B 458 PHE B 461 5 4 HELIX 22 22 THR B 465 ALA B 493 1 29 HELIX 23 23 THR B 496 SER B 527 1 32 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 CRYST1 60.584 99.810 173.098 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016506 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010019 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005777 0.00000